A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Mild cognitive impairment
- Focus Therapeutic Use
- Acronyms VITAL-Cog
- 30 Jan 2017 Planned End Date changed from 1 Oct 2017 to 1 Dec 2017.
- 30 Jan 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2017.
- 30 Jan 2017 Status changed from recruiting to active, no longer recruiting.